BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$126M
This Quarter Return
-2.57%
1 Year Return
+132.45%
3 Year Return
+197.53%
5 Year Return
–
10 Year Return
–
AUM
$307M
AUM Growth
+$307M
(+16%)
Cap. Flow
+$50.1M
Cap. Flow
% of AUM
16.3%
Top 10 Holdings %
Top 10 Hldgs %
95.94%
Holding
27
New
5
Increased
5
Reduced
2
Closed
3
Top Buys
| 1 |
Agilent Technologies
A
|
$26.5M |
| 2 |
CareDx
CDNA
|
$25.3M |
| 3 |
Revvity
RVTY
|
$19.6M |
| 4 |
Ginkgo Bioworks
DNA
|
$17.6M |
| 5 |
Twist Bioscience
TWST
|
$13.4M |
Top Sells
| 1 |
AMRS
Amyris Inc.
AMRS
|
$36.3M |
| 2 |
NeoGenomics
NEO
|
$23.2M |
| 3 |
Illumina
ILMN
|
$15.7M |
| 4 |
Guardant Health
GH
|
$13M |
| 5 |
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
|
$841K |
Sector Composition
| 1 | Healthcare | 97.85% |
| 2 | Technology | 0.88% |
| 3 | Financials | 0.43% |
| 4 | Communication Services | 0.27% |
| 5 | Consumer Discretionary | 0.21% |